News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
Sanofi-Aventis (France) Settles Further Eloxatin Patent Suits
April 6, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Sanofi-Aventis has settled a patent law suit over cancer drug Eloxatin with additional drugmakers, stopping them selling their generic versions in the United States from June 30 until August 2012.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Sanofi (France)
MORE ON THIS TOPIC
Legal
Judge Rules Against Semaglutide Compounders After Shortage Declared Over
April 25, 2025
·
2 min read
·
Tristan Manalac
Earnings
Tariff Uncertainty Reigns Over Q1 Earnings, With Merck Taking $200M Blow So Far
April 24, 2025
·
3 min read
·
Annalee Armstrong
Drug pricing
Trump Wants To Bring Back International Drug Pricing Policy:
Reuters
April 23, 2025
·
2 min read
·
Annalee Armstrong
Policy
RFK Considers Pulling COVID-19 From CDC’s Vaccine Guidelines for Children:
Politico
April 23, 2025
·
2 min read
·
Tristan Manalac
